Unknown

Dataset Information

0

Initial programmatic implementation of WHO option B in Botswana associated with increased projected MTCT.


ABSTRACT: : Botswana was one of the first African countries to transition from WHO Option A to Option B for prevention of mother-to-child HIV transmission (MTCT). We evaluated the impact of this transition on projected MTCT risk through review of 10,681 obstetric records of HIV-infected women delivering at 6 maternity wards. Compared with Option A, women receiving antenatal care under Option B were more likely to receive combination antiretroviral therapy (ART), adjusted odds ratio (aOR): 2.59 (95% confidence interval: 2.25 to 2.98), but they were also more likely to receive no antenatal antiretrovirals, aOR: 2.10 (95% confidence interval: 1.74 to 2.53). Consequently, initial implementation of Option B was associated with increased projected MTCT at 6 months of age, 3.79% under Option A and 4.69% under Option B (P < 0.001). Successful implementation of Option B or B+ may require that ART can be initiated within antenatal clinics, and novel strategies to remove barriers to rapid ART initiation.

SUBMITTER: Dryden-Peterson S 

PROVIDER: S-EPMC4326565 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Initial programmatic implementation of WHO option B in Botswana associated with increased projected MTCT.

Dryden-Peterson Scott S   Lockman Shahin S   Zash Rebecca R   Lei Quonhong Q   Chen Jennifer Y JY   Souda Sajini S   Petlo Chipo C   Dintwa Eldah E   Lebelonyane Refeletswe R   Mmalane Mompati M   Shapiro Roger L RL  

Journal of acquired immune deficiency syndromes (1999) 20150301 3


: Botswana was one of the first African countries to transition from WHO Option A to Option B for prevention of mother-to-child HIV transmission (MTCT). We evaluated the impact of this transition on projected MTCT risk through review of 10,681 obstetric records of HIV-infected women delivering at 6 maternity wards. Compared with Option A, women receiving antenatal care under Option B were more likely to receive combination antiretroviral therapy (ART), adjusted odds ratio (aOR): 2.59 (95% confid  ...[more]

Similar Datasets

| S-EPMC3987116 | biostudies-literature
| S-EPMC3196679 | biostudies-literature
| S-EPMC3898850 | biostudies-other
| S-EPMC7203194 | biostudies-literature
| S-EPMC7794061 | biostudies-literature
| S-EPMC3112252 | biostudies-literature
| S-EPMC9628413 | biostudies-literature
| S-EPMC7368220 | biostudies-literature
| S-EPMC7669431 | biostudies-literature
| S-EPMC2747124 | biostudies-literature